IMMUNE PROTECTION AGAINST EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS - OPTIMAL CONDITIONS AND ANALYSIS OF MECHANISM

被引:63
作者
COATES, A [1 ]
MACKAY, IR [1 ]
CRAWFORD, M [1 ]
机构
[1] ROY MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,CLIN RES UNIT,3050 MELBOURNE,AUSTRALIA
关键词
D O I
10.1016/0008-8749(74)90093-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:370 / 381
页数:12
相关论文
共 39 条
[1]  
ALLISON AC, 1971, LANCET, V2, P135
[2]  
ALLWOOD GG, 1972, CLIN EXP IMMUNOL, V11, P579
[4]  
ALVORD EC, 1970, HDB CLINICAL NEUROLO, V9
[5]  
ASHERSON GL, 1966, IMMUNOLOGY, V10, P179
[6]  
ASHERSON GL, 1971, CLIN EXP IMMUNOL, V9, P249
[7]   SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY CYTOTOXIC DRUGS [J].
CALNE, DB ;
LEIBOWITZ, S .
NATURE, 1963, 197 (487) :1309-&
[8]   MYELIN BASIC PROTEIN ADMINISTRATION IN MULTIPLE-SCLEROSIS [J].
CAMPBELL, B ;
VOGEL, PJ ;
FISHER, E ;
LORENZ, R .
ARCHIVES OF NEUROLOGY, 1973, 29 (01) :10-15
[9]   AMINO ACID SEQUENCE OF ENCEPHALITOGENIC BASIC PROTEIN FROM HUMAN MYELIN [J].
CARNEGIE, PR .
BIOCHEMICAL JOURNAL, 1971, 123 (01) :57-&
[10]  
CHAKRABARTY AK, 1971, J IMMUNOL, V106, P1389